Home/Filings/4/0001140361-15-042494
4//SEC Filing

VASCULAR SOLUTIONS INC 4

Accession 0001140361-15-042494

CIK 0001030206operating

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 4:09 PM ET

Size

10.5 KB

Accession

0001140361-15-042494

Insider Transaction Report

Form 4
Period: 2015-11-19
Transactions
  • Sale

    Common Stock

    2015-11-19$33.45/sh7,715$258,06719,320 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $6.39Exp: 2019-04-21Common Stock (10,000 underlying)
    10,000
  • Common Stock

    27,035
  • Stock Option (Right to Buy)

    Exercise: $9.61Exp: 2020-04-22Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $11.72Exp: 2021-04-22Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $11.63Exp: 2022-05-04Common Stock (10,000 underlying)
    10,000
Footnotes (2)
  • [F1]The price in column 4 is a weighted average price. The prices actually received for the stock ranged from $33.40 to $33.50 per share. Dr. Saucedo has provided to the Company, and upon request, will provide any security holder of the Company or the SEC staff information regarding the number of shares sold at each price within that range.
  • [F2]100% fully vested.

Documents

1 file

Issuer

VASCULAR SOLUTIONS INC

CIK 0001030206

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0001030206

Filing Metadata

Form type
4
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 4:09 PM ET
Size
10.5 KB